Standard Life plc:企業のM&A・事業提携・投資動向

◆英語タイトル:Standard Life plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1315
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:74
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Standard Life plc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Standard Life plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Standard Life plc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Standard Life plc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Standard Life plc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Standard Life plc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Standard Life plc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Standard Life plc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Standard Life plc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
DIVESTMENTS 32
Divestments – Overview 32
Divestments – Deal reports 33
APPENDIX 64
Contact Us 64
About MarketLine Financial Deals Database 64
Deal Definition and Methodology 66
About MarketLine 73

List of Tables
Table 1: Standard Life plc M&A volume and value trend (2014-YTD2018)
Table 2: Standard Life plc M&A activity by geography (2014-YTD2018)
Table 3: Standard Life plc divestments volume and value trend (2014-YTD2018)
Table 4: Standard Life plc divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Standard Life plc M&A volume and value trend (2014-YTD2018)
Figure 2: Standard Life plc M&A activity by geography (2014-YTD2018)
Figure 3: Standard Life plc divestments volume and value trend (2014-YTD2018)
Figure 4: Standard Life plc divestments by geography (2014-YTD2018)

★海外企業調査レポート[Standard Life plc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bial – Portela & Ca SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Bial - Portela & Ca SA (BIAL) is a pharmaceutical company that discovers, develops and provides drugs for neurosciences and cardiovascular therapeutic areas. The company offers products such as anti-inflammatories, anti-diabetics, cardiovascular, anti-asthmatics, antibiotics, antidepressants …
  • Genesee & Wyoming Inc.:企業のM&A・事業提携・投資動向
    Genesee & Wyoming Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Genesee & Wyoming Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Crown Bioscience Inc (6554):医療機器:M&Aディール及び事業提携情報
    Summary Crown Bioscience Inc (Crown Bioscience) is a drug discovery company that provides drug discovery and development services. The company offers antibodies, proteins, cell lines, tumor samples, in vivo and in vitro research reagents. It offers services such as preclinical research services, onc …
  • Planmeca Oy:企業の戦略的SWOT分析
    Planmeca Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Hillenbrand Inc (HI):企業の財務・戦略的SWOT分析
    Hillenbrand Inc (HI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SR One Ltd-製薬・医療分野:企業M&A・提携分析
    Summary SR One Ltd (SR One), a subsidiary of GlaxoSmithKline Plc is a venture capital firm that offers investment services for seed, start up, early and mid venture; and emerging growth companies. The firm invests globally in emerging life science companies that are pursuing innovative science which …
  • Blackbird Plc (BIRD):企業の財務・戦略的SWOT分析
    Summary Blackbird plc (Blackbird), formerly Forbidden Technologies plc, is a technology company that develops and commercializes cloud-based video technology. The company offers products such as FORscene- cloud-based post-production platform, captevate- online video editor and eva-video social netwo …
  • Electricity Generation Company of Bangladesh Ltd:企業の戦略的SWOT分析
    Electricity Generation Company of Bangladesh Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Goodwin Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Goodwin Biotechnology Inc (GBI), a subsidiary of Wallace Pharmaceuticals Pvt Ltd is a healthcare company that develops and manufactures vaccines, monoclonal antibodies, recombinant proteins and bioconjugates. The company offers cell culture, purification, bioconjugation, biosimilars, aseptic …
  • DNO ASA (DNO):企業の財務・戦略的SWOT分析
    Summary DNO ASA (DNO) is an oil and gas company that provides mineral properties exploration and development services. The company's services include selective and targeted drilling, fractured carbonate plays that are characteristic of the MENA region. It operates its oil and gas producing assets lo …
  • Genting Singapore Plc:戦略・SWOT・企業財務分析
    Genting Singapore Plc - Strategy, SWOT and Corporate Finance Report Summary Genting Singapore Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Lockheed Martin Corporation:戦略・SWOT・企業財務分析
    Lockheed Martin Corporation - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Pulai Group:企業の戦略・SWOT・財務分析
    Pulai Group - Strategy, SWOT and Corporate Finance Report Summary Pulai Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Argenx SE (ARGX):企業の財務・戦略的SWOT分析
    Summary Argenx SE (Argenx) is a human antibodies developer. The company offers autoimmunity and oncology products. Its wholly owned product candidates include ARGX-113, ARGX-110, ARGX-117 and ARGX-111. Argenx partnered product candidates are ARGX-109, ARGX-112, ARGX-115 AND ARGX-116. The company off …
  • Oriental Bank of Commerce:企業の戦略・SWOT・財務分析
    Oriental Bank of Commerce - Strategy, SWOT and Corporate Finance Report Summary Oriental Bank of Commerce - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Electricite de France SA (EDF)-石油・ガス分野:企業M&A・提携分析
    Summary Electricite de France S.A. (EDF) is a state-owned integrated energy company that generates, transmits, distributes and sells electricity; supplies natural gas; and offers energy services such as district heating, thermal energy services and other services. The group generates electricity fro …
  • LED Medical Diagnostics Inc (LMD):医療機器:M&Aディール及び事業提携情報
    Summary LED Medical Diagnostics Inc (LED Medical), a subsidiary of Searchlight Capital Corp, is a dental imaging technology. The company delivers imaging software and systems. Its products include Velscope Vx system, a device for the enhanced visualization of oral mucosal abnormalities; VELscope Vx …
  • Marine Harvest ASA:企業のM&A・事業提携・投資動向
    Marine Harvest ASA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Marine Harvest ASA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • OctreoPharm Sciences GmbH-医療機器分野:企業M&A・提携分析
    Summary OctreoPharm Sciences GmbH (OPS), a subsidiary of Ipsen SA is a clinical development biopharmaceutical company that develops radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company develops theranostic couple of antagonistic peptides for the diagnosis and treatme …
  • China Development Bank:企業の戦略・SWOT・財務分析
    China Development Bank - Strategy, SWOT and Corporate Finance Report Summary China Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆